<p>2025 年 9 月 17 日- 下午 4:00</p>
<p>加拿大不列颠哥伦比亚省温哥华 --（Newsfile Corp. -2025 年 9 月 17 日）- Burcon NutraScience Corporation（多伦多证券交易所代码：BU）（OTCQB 代码：BRCNF）（以下简称 “Burcon” 或 “公司”），作为植物基蛋白创新的全球技术领导者，欣然宣布 Philip Dowad 先生和 Richard Nazur Jr.先生成为其董事会的新成员。</p>
<p>“我们非常高兴在进入下一个增长阶段时欢迎 Phil 和 Richard 加入我们的董事会，” Burcon 董事会主席 Peter H. Kappel 表示。“Phil 在加拿大和美国证券监管要求方面拥有丰富的经验，而 Richard 在农业商品市场方面则具备深厚的专业知识。他们的指导将是无价的，我期待他们对我们的董事会和管理团队的贡献。”</p>
<p><strong>年度股东大会结果</strong></p>
<p>公司还宣布了其 2025 年年度股东大会和特别会议（以下简称 “<strong>会议</strong>”）的结果，该会议于 2025 年 9 月 17 日举行。所有在 Burcon 于 2025 年 8 月 1 日发布的管理代理通函中列出的七名提名人均被选为董事会成员。每位当选的董事将任职至 Burcon 下次年度股东大会结束，或直至其继任者被选举或任命，除非其职务根据 Burcon 的章程或适用法律提前 vacated。</p>
<p>董事选举投票结果如下：</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>董事提名人</strong></td>
<td><strong>赞成票</strong></td>
<td><strong>赞成票百分比</strong></td>
<td><strong>弃权票</strong></td>
<td><strong>弃权票百分比</strong></td>
<td><strong>未投票</strong></td>
</tr>
<tr>
<td>Alan Chan</td>
<td>5,792,102</td>
<td>99.45%</td>
<td>32,166</td>
<td>0.55%</td>
<td>178,446</td>
</tr>
<tr>
<td>Peter H. Kappel</td>
<td>5,776,452</td>
<td>99.18%</td>
<td>47,816</td>
<td>0.82%</td>
<td>178,446</td>
</tr>
<tr>
<td>Jeanne McCaherty</td>
<td>5,775,554</td>
<td>99.16%</td>
<td>48,714</td>
<td>0.84%</td>
<td>178,446</td>
</tr>
<tr>
<td>John A. Vassallo</td>
<td>5,675,004</td>
<td>97.44%</td>
<td>149,264</td>
<td>2.56%</td>
<td>178,446</td>
</tr>
<tr>
<td>James Peter Pekar</td>
<td>5,754,683</td>
<td>98.81%</td>
<td>69,585</td>
<td>1.19%</td>
<td>178,446</td>
</tr>
<tr>
<td>Philip James Dowad</td>
<td>4,177,313</td>
<td>71.72%</td>
<td>1,646,955</td>
<td>28.28%</td>
<td>178,446</td>
</tr>
<tr>
<td>Richard Nazur Jr.</td>
<td>5,763,535</td>
<td>98.96%</td>
<td>60,733</td>
<td>1.04%</td>
<td>178,446</td>
</tr>
</tbody>
</table>
<p>公司的股东还批准了 KPMG LLP 作为公司的审计师，并批准了对其未到期认股权证的行使价格的修订。</p>
<p><strong>Philip Dowad 简介</strong></p>
<p>Phil Dowad 曾是 KPMG 的审计和专业实践合伙人，拥有超过 43 年的经验，主要与全球公司合作，地点遍及加拿大。他在 KPMG 担任过高级职位，包括作为加拿大和美国证券合伙人，负责审查提交给两国证券监管机构的文件。自 2022 年退休以来，Dowad 先生一直担任北美实体的顾问，并在某些诉讼事务中担任专家证人。Dowad 先生曾是大温哥华 YMCA 的董事和审计委员会主席。</p>
<p><strong>Richard Nazur Jr. 简介</strong></p>
<p>Nazur 先生在农业商品市场工作超过 20 年，职业生涯始于 Archer Daniels Midland Company（“ADM”）。在 ADM 的六年期间，Nazur 先生参与了九种不同的农业商品，利用北美的所有物流运输方式。作为全球食品加工巨头，ADM 的农业服务部门负责在全球商品市场进行套利，以获取利润并确保广泛的加工设施网络的供应。在离开 ADM 之前，Nazur 先生担任小麦商品线经理，负责 ADM 在北美的小麦交易和物流部门。2012 年，Nazur 先生离开 ADM，成为独立的商品期货交易员。在过去的 13 年中，Nazur 先生运用其职业生涯中获得的经验，建立了一个成功的家族办公室，积极参与跨越五大洲的十多个商品市场，并定期在各种全国广播的农业节目中发表评论。</p>
<p><strong>关于 Burcon NutraScience Corporation</strong></p>
<p>Burcon 是食品和饮料行业高性能植物基蛋白的全球技术领导者。我们的商业成分提供卓越的口感、质地和功能，理想适合寻求下一代蛋白解决方案的配方师。凭借超过二十年的创新，Burcon 拥有广泛的专利组合，涵盖来自豌豆、油菜、黄豆、麻、向日葵和其他植物来源的新型蛋白。作为快速增长的植物基市场的关键参与者，Burcon 致力于可持续发展，并创造对人类和地球更好的一流蛋白解决方案。了解更多信息，请访问 www.burcon.ca。</p>
<p><strong>前瞻性信息警示声明</strong></p>
<p>多伦多证券交易所未对本信息内容的充分性进行审查，也不承担任何责任。本新闻稿包含根据 1995 年美国私人证券诉讼改革法案及适用的加拿大证券立法的定义的前瞻性陈述或前瞻性信息。前瞻性陈述或前瞻性信息涉及风险、不确定性及其他因素，这些因素可能导致实际结果、表现、前景和机会与此类前瞻性陈述所表达或暗示的内容存在重大差异。前瞻性陈述或前瞻性信息可以通过诸如 “预期”、“目标”、“打算”、“计划”、“目的”、“项目”、“估计”、“期望”、“相信”、“未来”、“可能”、“应当”、“可以”、“将会” 等词语及类似的对未来时期的引用来识别。本发布中包含的所有陈述，除了历史事实陈述外，均为前瞻性陈述。不能保证这些陈述将被证明是准确的，实际结果和未来事件可能与这些陈述或信息中预期的内容存在重大差异。可能导致实际结果与 Burcon 的计划和预期存在重大差异的重要因素包括我们商业模式和增长战略的实施；我们行业的趋势和竞争；我们未来的业务发展、财务状况和经营结果；以及我们以成本效益的方式获得融资的能力；政府法规的潜在变化，以及本文件中详细列出的其他风险和因素，以及 Burcon 不时向证券监管机构和证券交易所提交的文件，包括在 Burcon 截至 2025 年 3 月 31 日的年度信息表中的 “风险因素” 部分，以及其在 SEDAR+ 上向加拿大证券监管机构提交的其他公开文件，网址为 www.sedarplus.ca。此列表并非影响公司任何前瞻性陈述或信息的因素的详尽清单。任何前瞻性陈述或信息仅在作出之日有效，除非适用的证券法律要求，Burcon 不承担更新任何前瞻性陈述的意图或义务，无论是由于新信息、未来事件还是其他原因。尽管 Burcon 认为前瞻性陈述中固有的假设是合理的，但前瞻性陈述并不保证未来的表现，因此，投资者不应依赖此类陈述。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/1725/266880_464006475405c916_logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/1725/266880_464006475405c916_logo.jpg"/></p>
<p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/266880</p>
<p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/266880/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/266880/375"/></p>

BRCNF

<p>Burcon NutraScience Corporation 任命 Philip Dowad 和 Richard Nazur Jr. 为其董事会成员，增强了其领导力，进入新的增长阶段。该公司还报告了其 2025 年年度股东大会的结果，所有七位董事提名人均已当选。股东批准了 KPMG LLP 作为审计师，并修改了未到期认股权证的行使价格。Dowad 在证券监管方面拥有丰富的经验，而 Nazur 在农业商品市场有超过 20 年的经验。Burcon 专注于植物基蛋白创新，拥有显著的专利组合</p>

<p>09/17/2025 - 04:00 PM</p>
<div class="lb-trans"><p>2025 年 9 月 17 日- 下午 4:00</p>
</div><p>Vancouver, British Columbia--(Newsfile Corp. - September 17, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) (the &#34;Burcon&#34; or the &#34;Company&#34;), a global technology leader in plant-based protein innovation, is pleased to announce Mr. Philip Dowad and Mr. Richard Nazur Jr. as new members of its Board of Directors.</p>
<div class="lb-trans"><p>加拿大不列颠哥伦比亚省温哥华 --（Newsfile Corp. -2025 年 9 月 17 日）- Burcon NutraScience Corporation（多伦多证券交易所代码：BU）（OTCQB 代码：BRCNF）（以下简称 “Burcon” 或 “公司”），作为植物基蛋白创新的全球技术领导者，欣然宣布 Philip Dowad 先生和 Richard Nazur Jr.先生成为其董事会的新成员。</p>
</div><p>&#34;We are very pleased to welcome Phil and Richard to our board as we enter the next phase of growth,&#34; said Peter H. Kappel, Chair of Burcon's board of directors. &#34;Phil brings extensive experience in Canadian and U.S. securities regulatory requirements, while Richard offers deep expertise in agricultural commodity markets. Their guidance will be invaluable, and I look forward to their contributions to our board and management team.&#34;</p>
<div class="lb-trans"><p>“我们非常高兴在进入下一个增长阶段时欢迎 Phil 和 Richard 加入我们的董事会，” Burcon 董事会主席 Peter H. Kappel 表示。“Phil 在加拿大和美国证券监管要求方面拥有丰富的经验，而 Richard 在农业商品市场方面则具备深厚的专业知识。他们的指导将是无价的，我期待他们对我们的董事会和管理团队的贡献。”</p>
</div><p><strong>AGM Results</strong></p>
<div class="lb-trans"><p><strong>年度股东大会结果</strong></p>
</div><p>The Company also announces the results from its 2025 annual general and special meeting of shareholders (the &#34; <strong>Meeting</strong>&#34;) held on September 17, 2025. All of the seven nominees set out in Burcon's management proxy circular dated August 1, 2025 proposed by management for election to the board of directors at the Meeting were elected to the board. Each director elected will hold office until the conclusion of the next annual general meeting of shareholders of Burcon or until his or her successor is elected or appointed, unless his or her office is earlier vacated in accordance with Burcon's articles or with applicable law.</p>
<div class="lb-trans"><p>公司还宣布了其 2025 年年度股东大会和特别会议（以下简称 “<strong>会议</strong>”）的结果，该会议于 2025 年 9 月 17 日举行。所有在 Burcon 于 2025 年 8 月 1 日发布的管理代理通函中列出的七名提名人均被选为董事会成员。每位当选的董事将任职至 Burcon 下次年度股东大会结束，或直至其继任者被选举或任命，除非其职务根据 Burcon 的章程或适用法律提前 vacated。</p>
</div><p>The results of the voting on the election of the directors are as follows:</p>
<div class="lb-trans"><p>董事选举投票结果如下：</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Director Nominee</strong></td>
<td><strong>Votes For</strong></td>
<td><strong>% Votes For</strong></td>
<td><strong>Votes Withheld</strong></td>
<td><strong>% Votes Withheld</strong></td>
<td><strong>Non Votes</strong></td>
</tr>
<tr>
<td>Alan Chan</td>
<td>5,792,102</td>
<td>99.45%</td>
<td>32,166</td>
<td>0.55%</td>
<td>178,446</td>
</tr>
<tr>
<td>Peter H. Kappel</td>
<td>5,776,452</td>
<td>99.18%</td>
<td>47,816</td>
<td>0.82%</td>
<td>178,446</td>
</tr>
<tr>
<td>Jeanne McCaherty</td>
<td>5,775,554</td>
<td>99.16%</td>
<td>48,714</td>
<td>0.84%</td>
<td>178,446</td>
</tr>
<tr>
<td>John A. Vassallo</td>
<td>5,675,004</td>
<td>97.44%</td>
<td>149,264</td>
<td>2.56%</td>
<td>178,446</td>
</tr>
<tr>
<td>James Peter Pekar</td>
<td>5,754,683</td>
<td>98.81%</td>
<td>69,585</td>
<td>1.19%</td>
<td>178,446</td>
</tr>
<tr>
<td>Philip James Dowad</td>
<td>4,177,313</td>
<td>71.72%</td>
<td>1,646,955</td>
<td>28.28%</td>
<td>178,446</td>
</tr>
<tr>
<td>Richard Nazur Jr.</td>
<td>5,763,535</td>
<td>98.96%</td>
<td>60,733</td>
<td>1.04%</td>
<td>178,446</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>董事提名人</strong></td>
<td><strong>赞成票</strong></td>
<td><strong>赞成票百分比</strong></td>
<td><strong>弃权票</strong></td>
<td><strong>弃权票百分比</strong></td>
<td><strong>未投票</strong></td>
</tr>
<tr>
<td>Alan Chan</td>
<td>5,792,102</td>
<td>99.45%</td>
<td>32,166</td>
<td>0.55%</td>
<td>178,446</td>
</tr>
<tr>
<td>Peter H. Kappel</td>
<td>5,776,452</td>
<td>99.18%</td>
<td>47,816</td>
<td>0.82%</td>
<td>178,446</td>
</tr>
<tr>
<td>Jeanne McCaherty</td>
<td>5,775,554</td>
<td>99.16%</td>
<td>48,714</td>
<td>0.84%</td>
<td>178,446</td>
</tr>
<tr>
<td>John A. Vassallo</td>
<td>5,675,004</td>
<td>97.44%</td>
<td>149,264</td>
<td>2.56%</td>
<td>178,446</td>
</tr>
<tr>
<td>James Peter Pekar</td>
<td>5,754,683</td>
<td>98.81%</td>
<td>69,585</td>
<td>1.19%</td>
<td>178,446</td>
</tr>
<tr>
<td>Philip James Dowad</td>
<td>4,177,313</td>
<td>71.72%</td>
<td>1,646,955</td>
<td>28.28%</td>
<td>178,446</td>
</tr>
<tr>
<td>Richard Nazur Jr.</td>
<td>5,763,535</td>
<td>98.96%</td>
<td>60,733</td>
<td>1.04%</td>
<td>178,446</td>
</tr>
</tbody>
</table>
</div><p>Shareholders of the Company also approved the appointment of KPMG LLP as auditors of the Company and the amendment to the exercise price of its outstanding warrants.</p>
<div class="lb-trans"><p>公司的股东还批准了 KPMG LLP 作为公司的审计师，并批准了对其未到期认股权证的行使价格的修订。</p>
</div><p><strong>Philip Dowad Bio</strong></p>
<div class="lb-trans"><p><strong>Philip Dowad 简介</strong></p>
</div><p>Phil Dowad was an audit and professional practice partner of KPMG with over 43 years of experience working with global companies primarily based out of locations across Canada. He held senior positions within KPMG including as a Canadian and U.S. securities partner reviewing filing documents prior to their filing with securities regulators in both countries. Since his retirement in 2022, Mr. Dowad has acted as a consultant to North American based entities as well as acting as an expert witness in certain litigation matters. Mr. Dowad is a former director and Chairman of the Audit Committee of the YMCA of Greater Vancouver.</p>
<div class="lb-trans"><p>Phil Dowad 曾是 KPMG 的审计和专业实践合伙人，拥有超过 43 年的经验，主要与全球公司合作，地点遍及加拿大。他在 KPMG 担任过高级职位，包括作为加拿大和美国证券合伙人，负责审查提交给两国证券监管机构的文件。自 2022 年退休以来，Dowad 先生一直担任北美实体的顾问，并在某些诉讼事务中担任专家证人。Dowad 先生曾是大温哥华 YMCA 的董事和审计委员会主席。</p>
</div><p><strong>Richard Nazur Jr. Bio</strong></p>
<div class="lb-trans"><p><strong>Richard Nazur Jr. 简介</strong></p>
</div><p>Mr. Nazur has been involved in the agricultural commodity markets for over 20 years, beginning his career at Archer Daniels Midland Company (&#34;ADM&#34;). During his six years at ADM, Mr. Nazur was involved in nine different agricultural commodities leveraging all logistical conveyances in North America. Being a global food processing powerhouse, ADM's Ag services unit oversaw arbitraging global commodity markets for both profit and to secure supplies for the vast network of processing facilities. Prior to his departure from ADM, Mr. Nazur was Wheat Commodity Line Manager and oversaw ADM's North American wheat trading and logistics segments. In 2012, Mr. Nazur left ADM and became an independent commodity futures trader. In the last 13 years, Mr. Nazur has applied the experience gained over his career to build a successful family office that is actively involved in over ten different commodity markets that span across five different continents and is a regular commentator on various nationally broadcasted agricultural shows.</p>
<div class="lb-trans"><p>Nazur 先生在农业商品市场工作超过 20 年，职业生涯始于 Archer Daniels Midland Company（“ADM”）。在 ADM 的六年期间，Nazur 先生参与了九种不同的农业商品，利用北美的所有物流运输方式。作为全球食品加工巨头，ADM 的农业服务部门负责在全球商品市场进行套利，以获取利润并确保广泛的加工设施网络的供应。在离开 ADM 之前，Nazur 先生担任小麦商品线经理，负责 ADM 在北美的小麦交易和物流部门。2012 年，Nazur 先生离开 ADM，成为独立的商品期货交易员。在过去的 13 年中，Nazur 先生运用其职业生涯中获得的经验，建立了一个成功的家族办公室，积极参与跨越五大洲的十多个商品市场，并定期在各种全国广播的农业节目中发表评论。</p>
</div><p><strong>About Burcon NutraScience Corporation</strong></p>
<div class="lb-trans"><p><strong>关于 Burcon NutraScience Corporation</strong></p>
</div><p>Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality-ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at www.burcon.ca.</p>
<div class="lb-trans"><p>Burcon 是食品和饮料行业高性能植物基蛋白的全球技术领导者。我们的商业成分提供卓越的口感、质地和功能，理想适合寻求下一代蛋白解决方案的配方师。凭借超过二十年的创新，Burcon 拥有广泛的专利组合，涵盖来自豌豆、油菜、黄豆、麻、向日葵和其他植物来源的新型蛋白。作为快速增长的植物基市场的关键参与者，Burcon 致力于可持续发展，并创造对人类和地球更好的一流蛋白解决方案。了解更多信息，请访问 www.burcon.ca。</p>
</div><p><strong>Forward-Looking Information Cautionary Statement</strong></p>
<div class="lb-trans"><p><strong>前瞻性信息警示声明</strong></p>
</div><p>The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as &#34;anticipate,&#34; &#34;aim&#34;, &#34;intend,&#34; &#34;plan,&#34; &#34;goal,&#34; &#34;project,&#34; &#34;estimate,&#34; &#34;expect,&#34; &#34;believe,&#34; &#34;future,&#34; &#34;likely,&#34; &#34;may,&#34; &#34;should,&#34; &#34;could,&#34; &#34;will&#34; and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled &#34;Risk Factors&#34; in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.</p>
<div class="lb-trans"><p>多伦多证券交易所未对本信息内容的充分性进行审查，也不承担任何责任。本新闻稿包含根据 1995 年美国私人证券诉讼改革法案及适用的加拿大证券立法的定义的前瞻性陈述或前瞻性信息。前瞻性陈述或前瞻性信息涉及风险、不确定性及其他因素，这些因素可能导致实际结果、表现、前景和机会与此类前瞻性陈述所表达或暗示的内容存在重大差异。前瞻性陈述或前瞻性信息可以通过诸如 “预期”、“目标”、“打算”、“计划”、“目的”、“项目”、“估计”、“期望”、“相信”、“未来”、“可能”、“应当”、“可以”、“将会” 等词语及类似的对未来时期的引用来识别。本发布中包含的所有陈述，除了历史事实陈述外，均为前瞻性陈述。不能保证这些陈述将被证明是准确的，实际结果和未来事件可能与这些陈述或信息中预期的内容存在重大差异。可能导致实际结果与 Burcon 的计划和预期存在重大差异的重要因素包括我们商业模式和增长战略的实施；我们行业的趋势和竞争；我们未来的业务发展、财务状况和经营结果；以及我们以成本效益的方式获得融资的能力；政府法规的潜在变化，以及本文件中详细列出的其他风险和因素，以及 Burcon 不时向证券监管机构和证券交易所提交的文件，包括在 Burcon 截至 2025 年 3 月 31 日的年度信息表中的 “风险因素” 部分，以及其在 SEDAR+ 上向加拿大证券监管机构提交的其他公开文件，网址为 www.sedarplus.ca。此列表并非影响公司任何前瞻性陈述或信息的因素的详尽清单。任何前瞻性陈述或信息仅在作出之日有效，除非适用的证券法律要求，Burcon 不承担更新任何前瞻性陈述的意图或义务，无论是由于新信息、未来事件还是其他原因。尽管 Burcon 认为前瞻性陈述中固有的假设是合理的，但前瞻性陈述并不保证未来的表现，因此，投资者不应依赖此类陈述。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/1725/266880_464006475405c916_logo.jpg" alt="" original-src="https://images.newsfilecorp.com/files/1725/266880_464006475405c916_logo.jpg"/></p>
<p>To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266880</p>
<div class="lb-trans"><p>要查看本新闻稿的源版本，请访问 https://www.newsfilecorp.com/release/266880</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/266880/375" alt="" original-src="https://api.newsfilecorp.com/newsinfo/266880/375"/></p>

Burcon 宣布新董事会成员及股东大会结果 | BRCNF 股票新闻